IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 1 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,582,028 | -79.4% | 165,357 | -76.2% | 0.04% | -78.7% |
| Q2 2023 | $41,610,021 | +15.9% | 693,963 | -4.4% | 0.18% | +1.1% |
| Q1 2023 | $35,891,314 | +5.0% | 725,957 | +21.3% | 0.18% | -15.4% |
| Q4 2022 | $34,168,551 | +45.3% | 598,713 | +19.5% | 0.21% | +38.7% |
| Q3 2022 | $23,520,000 | – | 501,067 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $17,200,000 | 9.25% |
| Velan Capital Investment Management LP | 293,385 | $8,772,000 | 8.14% |
| Paradigm Biocapital Advisors LP | 499,190 | $14,926,000 | 3.95% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $11,529,000 | 2.31% |
| Rock Springs Capital Management LP | 2,552,034 | $76,306,000 | 1.92% |
| Samsara BioCapital, LLC | 160,963 | $4,813,000 | 1.21% |
| RTW INVESTMENTS, LP | 1,859,471 | $55,598,000 | 1.15% |
| Pier Capital, LLC | 236,616 | $7,075,000 | 0.90% |
| Avidity Partners Management LP | 1,363,800 | $40,778,000 | 0.85% |
| Rhenman & Partners Asset Management AB | 170,472 | $5,097,000 | 0.50% |